News: $EYEG EyeGate Receives Approval from FDA to Initiate PRK Pivotal Study
WALTHAM, MA / ACCESSWIRE / June 3, 2019 / EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) ("EyeGate" or "the Company") announced today it has received approval from the U.S. Food and Drug Administration ("FDA") to initiate its photorefractive keratectomy ("PRK") pivotal study. The FDA has deter...
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.